Correlation between <i>Acinetobacter baumannii</i> Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models
<i>Acinetobacter baumannii</i> is one of the most difficult-to-treat pathogens worldwide, due to developed resistance. The aim of this study was to evaluate the use of widely prescribed antimicrobials and the respective resistance rates of <i>A. baumannii,</i> and to explore...
Main Authors: | Rania Kousovista, Christos Athanasiou, Konstantinos Liaskonis, Olga Ivopoulou, George Ismailos, Vangelis Karalis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/4/480 |
Similar Items
-
Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01) -
Association of Antibiotic Use with the Resistance Epidemiology of <i>Pseudomonas aeruginosa</i> in a Hospital Setting: A Four-Year Retrospective Time Series Analysis
by: Rania Kousovista, et al.
Published: (2021-03-01) -
Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis
by: Jiang Z, et al.
Published: (2018-08-01) -
A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii
by: Mohammed Ali M.Marie, et al.
Published: (2015-10-01) -
In vitro activity of meropenem, imipenem, cefepime, cefoxitin and ciprofloxacin against multiresistant Klebsiella pneumoniae.
by: P Pruekprasert, et al.
Published: (2006-06-01)